Anti-estrogens and aromatase inhibitors: tamoxifen and testolactone.
Sciarra
F
F
Istituto di V Clinica Medica Generale, Policlinico Umberto I, Università La Sapienza, Roma, Italy.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D047072:Aromatase Inhibitors; D001941:Breast Diseases / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D006177:Gynecomastia / Q000188:drug therapy; D006728:Hormones / Q000097:blood; D006801:Humans; D006965:Hyperplasia; D007246:Infertility / Q000188:drug therapy; D008297:Male; D011247:Pregnancy; D011467:Prostate / Q000473:pathology; D011628:Puberty, Delayed / Q000188:drug therapy; D011629:Puberty, Precocious / Q000188:drug therapy; D013629:Tamoxifen / Q000494:pharmacology* / Q000627:therapeutic use; D013738:Testolactone / Q000494:pharmacology* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists; D006728:Hormones; D013629:Tamoxifen; D013738:Testolactone